Department of Chemical Sciences, Pharmasset, Inc., Tucker, Georgia, USA.
Abstract:
A series of N3, 5-Anhydro-4-(beta-D-ribofuranosyl)-8-azapurin-2-ones were prepared in multistep reactions from uridine as potential anti-hepatitis C virus (HCV) agents. The synthetic details as well as biological evaluations are discussed.